Structure and orientation study of fusion peptide FP23 of gp41 from HIV-1 alone or inserted into various lipid membrane models (mono-, bi- and multibi-layers) by FT-IR spectroscopies and Brewster angle microscopy

Biochimica et Biophysica Acta - Biomembranes

Volumn 1715, Issue 2, 2005, Pages 81-95

  Castano, Sabine ^a   Desbat, Bernard ^a  

^a CNRS   (France)

Author keywords

ATR spectroscopy; Brewster angle microscopy; Fusion peptide FP23; Lipid bound structure; Peptide orientation; PMIRRAS

Indexed keywords

CARBENE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLCHOLINE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIOLEOYLPHOSPHATIDYLGLYCEROL; FUSION PEPTIDE FP23; GLYCOPROTEIN GP 41; HYBRID PROTEIN; LIPID; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS PROTEIN; WATER;

ABSORPTION SPECTROSCOPY; AIR; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; ATTENUATED TOTAL REFLEXION SPECTROSCOPY; BREWSTER ANGLE MICROSCOPY; DILUTION; GENETIC POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS 1; INFRARED SPECTROSCOPY; LIPID MEMBRANE; NONHUMAN; POLARIZATION; POLARIZATION MODULATION INFRARED REFLECTION ABSORPTION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN STRUCTURE; SIMULATION;

AMINO ACID SEQUENCE; HIV ENVELOPE PROTEIN GP41; HIV-1; LIPID BILAYERS; MICROSCOPY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 24044479637     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.07.008     Document Type: Article

References (74)

1. F.D. Veronese, A.L. DeVico, T.D. Copeland, S. Oroszlan, R.C. Gallo, and M.G. Sarngadharan Characterization of gp41 as the transmembrane protein coded by the HTLV/LAV envelope gene Science 229 1985 1402 1405
2. L.D. Hernandez, L.R. Hoffman, T.G. Wolfsberg, and J.M. White Virus-cell and cell-cell fusion Annu. Rev. Cell Dev. Biol. 12 1996 627 661
3. D.S. Dimitrov Cell biology of virus entry Cell 101 2000 697 702
4. D.M. Eckert, and P.S. Kim Mechanisms of viral membrane fusion and its inhibition Annu. Rev. Biochem. 70 2001 777 810
5. R. Blumenthal, M.J. Clague, S.R. Durell, and R.M. Epand Membrane fusion Chem. Rev. 103 2003 53 69
6. D.C. Chan, D. Fass, J.M. Berger, and P.S. Kim Core structure of gp41 from the HIV envelope glycoprotein Cell 89 1997 263 273
7. E.O. Freed, D.J. Myers, and R. Risser Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41 Proc. Natl. Acad. Sci. U. S. A. 87 1990 4650 4654
8. E.O. Freed, E.L. Delwart, G.L. Buchschacher Jr., and A.T. Panganiban A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity Proc. Natl. Acad. Sci. U. S. A. 89 1992 70 74
9. M. Rafalsky, J.D. Lear, and W.F. De Grado Phospholipid interactions of the synthetic peptides representing the N-terminus of HIV gp41 Biochemistry 29 1990 7917 7922
10. V.A. Slepushkin, S.M. Andreev, M.V. Sidorova, G.B. Melikyan, V.B. Grigoriev, V.M. Chumakov, A.E. Grinfeldt, R.A. Manukyan, and E.V. Karamov Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function AIDS Res. Hum. Retrovir. 8 1992 9 18
11. I. Martin, F. Defrise-Quertain, E. Decroly, M. Vandenbranden, R. Brasseur, and J.M. Ruysschaert Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes Biochim. Biophys. Acta 1145 1993 124 133
12. I. Martin, H. Schaal, A. Scheid, and J.M. Ruysschaert Lipid membrane fusion induced by the human immunodeficiency virus type I gp41 N-terminal extremity is determined by its orientation in the lipid bilayer J. Virol. 70 1996 298 304
13. J.L. Nieva, S. Nir, A. Muga, F.M. Goni, and J. Wilschut Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage Biochemistry 33 1994 3201 3209
14. J.L. Nieva, S. Nir, and J. Wilschut Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a beta-type structure of the HIV-1 fusion peptide J. Liposome Res. 8 1998 165 182
15. P.W. Mobley, H.F. Lee, C.C. Curtain, A. Kirkpatrick, A.J. Waring, and L.M. Gordon The amino-terminal peptide of HIV-1 glycoprotein 41 fuses human erythrocytes Biochim. Biophys. Acta 1271 1995 304 314
16. H. Schaal, M. Klein, P. Gehrmann, O. Adams, and A. Scheid Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion J. Virol. 69 1995 3308 3314
17. M.D. Delahunty, I. Rhee, E.O. Freed, and J.S. Bonifacino Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues Virology 218 1996 94 102
18. S.R. Durell, I. Martin, J.M. Ruysschaert, Y. Shai, and R. Blumenthal What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review) Mol. Membr. Biol. 14 1997 97 112
19. Y. Kliger, A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y. Shai Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study J. Biol. Chem. 272 1997 13496 13505
20. F.B. Pereira, F.M. Goni, A. Muga, and J.L. Nieva Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects Biophys. J. 73 1997 1977 1986
21. E. Pecheur, J. Sainte-Marie, A. Bienvenue, and D. Hoekstra Peptides and membrane fusion: towards an understanding of the molecular mechanism of protein-induced fusion J. Membr. Biol. 167 1999 1 17
22. M. Pritsker, J. Rucker, T.L. Hoffman, R.W. Doms, and Y. Shai Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes Biochemistry 38 1999 11359 11371
23. L.M. Gordon, C.C. Curtain, Y.C. Zhong, A. Kirkpatrick, P.W. Mobley, and A.J. Waring The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocytes membranes: peptide conformation, orientation and aggregation Biochim. Biophys. Acta 1139 1992 257 272
24. D.K. Chang, W.J. Chien, and S.F. Cheng The FLG motif in the N-terminal region of glucoprotein 41 of human immunodeficiency virus type 1 adopts a type-I beta turn in aqueous solution and serves as the initiation site for helix formation Eur. J. Biochem. 247 1997 896 905
25. A.J. Waring, P.W. Mobley, and L.M. Gordon Conformational mapping of a viral fusion peptide in structure-promoting solvents using circular dichroism and electrospray mass spectrometry Proteins 2 1998 38 49
26. D.K. Chang, S.F. Cheng, and W.J. Chien The amino-terminal fusion domain of the human immunodeficiency virus type I gp41 inserts into the SDS micelle primarily as α helix with a conserved glycine at the micelle-water interface J. Virol. 71 1997 6593 6602
27. K.F. Morris, X. Gao, and T.C. Wong The interactions of the HIV gp41 fusion peptides with zwitterionic membrane mimics determined by NMR spectroscopy Biochim. Biophys. Acta 1667 2004 67 81
28. J. Yang, P.D. Parkanzky, B.A. Khunte, C.G. Canlas, R. Yang, C.M. Gabrys, and D.P. Weliky Solid state NMR measurements of conformation and conformational distributions in the membrane-bound HIV-1 fusion peptide J. Mol. Graph. Model. 19 2001 129 135
29. J. Yang, M. Gabrys, and D.P. Weliky Solid-state NMR evidence for an extended β strand conformation of the membrane bound HIV-1 fusion peptide Biochemistry 40 2001 8126 8137
30. J. Yang, and D.P. Weliky Solid-state nuclear magnetic resonance evidence for parallel and antiparallel strand arrangements in the membrane-associated HIV-1 fusion peptide Biochemistry 42 2003 11879 11890
31. J. Yang, M. Prorok, F.J. Castellino, and D.P. Weliky Oligomeric β-structure of the membrane bound HIV-1 fusion peptide formed from soluble monomers Biophys. J. 87 2004 1951 1963
32. C. Curtain, F. Separovic, K. Nielsen, D. Craik, Y. Zhong, and A. Kirkpatrick The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids Eur. Biophys. J. 28 1999 427 436
33. S.G. Peisajovich, R.Q. Epand, M. Pritsker, Y. Shai, and R.M. Epand The polar region consecutive to the HIV fusion peptide participates in membrane fusion Biochemistry 39 2000 1826 1833
34. P.W. Mobley, A.J. Waring, M.A. Sherman, and L.M. Gordon Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs Biochim. Biophys. Acta 1418 1999 1 18
35. A. Saez-Cirion, and J.L. Nieva Conformational transitions of membrane-bound HIV-1 fusion peptide Biochim. Biophys. Acta 1564 2002 57 65
36. D. Blaudez, T. Buffeteau, J.C. Cornut, B. Desbat, N. Escafre, M. Pezolet, and J.M. Turlet Polarization modulation IRFT spectroscopy at the air-water interface Thin Solid Films 242 1994 146 150
37. E. Goormaghtigh, V. Cabiaux, and J.M. Ruysschaert Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier transform infra-red spectroscopy on hydrated films Eur. J. Biochem. 193 1990 409 420
38. E. Goormaghtigh, V. Cabiaux, and J.M. Ruysschaert Determination of soluble and membrane protein structure by Fourier Transform Infrared spectroscopy H.J. Hilderson G.B. Ralston Subcellular Biochemistry Physicochemical Methods in the Study of Biomembranes vol. 23 1994 Plenum Press New York 329 450
39. E. Goormaghtigh, V. Raussens, and J.M. Ruysschaert Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes Biochim. Biophys. Acta 1422 1999 105 185
40. T. Buffeteau, D. Blaudez, E. Péré, and B. Desbat Optical constant determination in the infrared of the uniaxially oriented monolayers from transmittance and reflectance measurements J. Phys. Chem., B 103 1999 5020 5027
41. F. Abeles, and M.L. Théye Méthode de calcul des constantes optiques des couches minces absorbantes à partir de mesures de réflexion et de transmission Surf. Sci. 5 1966 325 331
42. J.D. Graybeal Molecular Spectroscopy 1988 Mac Graw Hill, Inc. New York 665
43. 2-)n J. Chem. Phys. 35 1961 693 713
44. T. Miyazawa G.D. Fasman M. Dekker Poly-α Amino Acids, Chapter 2 1967 New York 69 103
45. T. Buffeteau, E. Le Calvez, S. Castano, B. Desbat, D. Blaudez, and J. Dufourcq Anisotropic optical constants of α-helix and β-sheet secondary structures in the infrared J. Phys. Chem., B 104 2000 4537 4544
46. T. Miyazawa, and E.R. Blout The infrared spectra of polypeptides in various conformations: amide I and II bands J. Am. Chem. Soc. 83 1961 712 719
47. W.H. Moore, and S. Krimms Vibrational analysis of peptides, polypeptides, and proteins: II. β-Poly(l-alanine) and βpoly(l-alanylglycine) Biopolymers 5 1976 2465 2483
48. P.I. Haris, and D. Chapman Does Fourier-transform infrared spectroscopy provide useful information on protein structure? TIBS 17 1992 328 333
49. W.K. Surewicz, H.H. Mantsch, and D. Chapman Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment Biochemistry 32 1993 389 394
50. I. Cornut, B. Desbat, J.M. Turlet, and J. Dufourcq In situ study by polarization modulated Fourier transform infrared spectroscopy of the structure and orientation of lipids and amphipathic peptides at the air/water interface Biophys. J. 70 1996 305 312
51. j(i = 2j) peptides Biochim. Biophys. Acta 1416 1999 176 194
52. mK peptides Biochim. Biophys. Acta 1463 2000 65 80
53. G. Socrates Infrared Characteristic Group Frequencies 1980 John Wiley and Sons New York
54. H.H. Mantsch, and R.N. Mc Elhaney Phospholipid phase transitions in model and biological membranes as studied by infrared spectroscopy Chem. Phys. Lipids 57 1991 213 226
55. I.M. Asher, and I.W. Levin Effects of temperature and molecular interactions on the vibrational infrared spectra of phospholipid vesicles Biochim. Biophys. Acta 468 1977 63 72
56. D.G. Cameron, H.L. Casal, and H.H. Mantsch Characterization of the pretransition in 1,2-dipalmitoyl-sn-glycero-3-phosphocholine by Fourier transform infrared spectroscopy Biochemistry 19 1980 3665 3672
57. M.W. Rooney, Y. Lange, and J.W. Kauffman Acyl chain organization and protein secondary structure in cholesterol-modified erythrocyte membranes J. Biol. Chem. 259 1984 8281 8285
58. J.W. Brauner, R. Mendelsohn, and F.G. Prendergast Attenuated total reflectance Fourier transform infrared studies of the interaction of melittin, two fragments of melittin, and (hemolysin with phosphatidylcholines Biochemistry 26 1987 8151 8158
59. L.M. Gordon, P.W. Mobley, R. Pilpa, M.A. Sherman, and A.J. Waring Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using 13C-enhanced Fourier transform infrared spectroscopy Biochim. Biophys. Acta 1559 2002 96 120
60. M.L. Bodner, C.M. Gabrys, P.D. Parkanzky, J. Yang, C.A. Duskin, and D.P. Weliky Temperature dependence and resonance assignment of 13C NMR spectra of selectively and uniformly labeled fusion peptides associated with membranes Magn. Reson. Chem. 42 2004 187 194
61. D. Rapaport, and Y. Shai Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes J. Biol. Chem. 26 1994 15124 15131
62. R.W. Doms, and J.P. Moore HIV-1 membrane fusion: targets of opportunity J. Cell Biol. 151 2000 F9 F14
63. R.M. Epand Lipid polymorphism and protein-lipid interactions Biochim. Biophys. Acta 1376 1998 353 368
64. S. Afonin, R.W. Glaser, M. Berditchevskaia, P. Wadhwani, K.H. Guhrs, U. Mollmann, A. Perner, and A.S. Ulrich 4-Fluorophenylglycine as a label for 19F NMR structure analysis of membrane-associated peptides ChemBioChem 4 2003 1151 1163
65. R. Brasseur, M. Vandenbranden, B. Cornet, A. Burny, and J.M. Ruysschaert Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins Biochim. Biophys. Acta 1029 1990 267 273
66. S. Karnath, and T.C. Wong Membrane structure of the human immunodeficiency virus gp41 fusion domain by molecular dynamics simulation Biophys. J. 83 2002 135 143
67. T.C. Wong Membrane structure of the human immunodeficiency virus gp41 fusion peptide by molecular dynamics simulation: II. Glycine mutants Biochim. Biophys. Acta 1609 2003 45 54
68. M.W. Maddox, and M.L. Longo Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes Biophys. J. 83 2002 3088 3096
69. I. Martin, R.M. Epand, and J.M. Ruysschaert Structural properties of the putative fusion peptide of fertilin, a protein active in sperm-egg fusion, upon interaction with the lipid bilayer Biochemistry 37 1998 17030 17039
70. B. Adam, L. Lins, V. Stroobant, A. Thomas, and R. Brasseur Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide J. Virol. 78 2004 2131 2136
71. A. Colotto, I. Martin, J.M. Ruysschaert, A. Sen, S.W. Hui, and R.M. Epand Structural study of the interaction between the SIV fusion peptide and model membranes Biochemistry 35 1996 980 989
72. A. Schanck, J. Peuvot, and R. Brasseur Influence of the mode of insertion of SIV peptides into membranes on the structure of model membrane as studied by 31P NMR Biochem. Biophys. Res. Commun. 250 1998 12 14
73. J.P. Bradshaw, M.J. Darkes, T.A. Harroun, J. Katsaras, and R.M. Epand Oblique membrane insertion of viral fusion peptide probed by neutron diffraction Biochemistry 39 2000 6581 6585
74. J. Luneberg, I. Martin, F. Nussler, J.M. Ruysschaert, and A. Herrmann Structure and topology of the influenza virus fusion peptide in lipid bilayers J. Biol. Chem. 270 1995 27606 27614